SureTrader Nadex Advertisement SureTrader
Home > Boards > US Listed > Biotechs >

vTv Therapeutics (VTVT)

VTVT RSS Feed
Add VTVT Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 3/27/2017 11:56:28 AM - Followers: 9 - Board type: Free - Posts Today: 0
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
VTVT
Current Price
Volume:
Bid Ask Day's Range
SureTrader
VTVT News: Statement of Changes in Beneficial Ownership (4) 04/03/2017 06:55:45 PM
VTVT News: Current Report Filing (8-k) 03/29/2017 08:01:59 AM
VTVT News: Current Report Filing (8-k) 03/27/2017 04:32:04 PM
VTVT News: Confidential Treatment Order (ct Order) 03/27/2017 10:50:20 AM
VTVT News: Additional Proxy Soliciting Materials (definitive) (defa14a) 03/20/2017 07:06:05 AM
PostSubject
#34   Request to extend confidential treatment order http://services.corporate-ir.net Amatuer17 03/27/17 11:56:28 AM
#33   Here are 2 more links on the stopped trial https://pdfs.semanticscholar.org/018 Amatuer17 03/19/17 09:29:49 PM
#32   Thanks for analysis and your read on it. Alz Amatuer17 03/19/17 09:18:35 PM
#31   As I understand it, they can't start further scottsmith 03/19/17 08:46:36 PM
#30   The Roth conference call is very good to Amatuer17 03/19/17 08:12:58 PM
#29   Looks like this stock is overlooked and has Amatuer17 03/19/17 11:52:52 AM
#28   Neurotrope’s Novel Therapy to Treat Alzheimer’s Disease drbio45 01/07/17 09:01:58 AM
#27   "...aberrant oxidative stress and inflammation play a key Cbdpotential 01/06/17 07:10:38 AM
#26   VTVT reports phase-2 data for TTP273 in T2D: DewDiligence 12/14/16 05:51:21 PM
#25   VTVT had $51.1M cash at 9/30/16—(excluding the recently DewDiligence 11/02/16 04:59:40 PM
#24   VTVT borrows up to $25M from Silicon Valley DewDiligence 10/31/16 07:40:53 AM
#23   VTVT completes enrollment in first part of phase-3 DewDiligence 09/07/16 11:13:25 AM
#22   VTVT completes enrollment of TTP273 phase-2 trial: #msg-124553925. DewDiligence 08/16/16 09:46:48 AM
#21   VTVT +9% on topline data for TTP399 in T2D: DewDiligence 08/10/16 09:36:06 AM
#20   VTVT had ~$57M cash net of current liabilities DewDiligence 08/03/16 09:19:45 AM
#18   Ha thanks but 77%? Still huge. buckiii2 07/14/16 09:14:44 PM
#17   Not the same Steve Cohen, LOL. The famous DewDiligence 07/14/16 08:34:24 PM
#16   13 D/A. buckiii2 07/14/16 07:29:44 PM
#15   Steve Cohen has 77% of this?Where did you DewDiligence 07/14/16 07:26:18 PM
#14   Present at AAIC 27 July 16. Steve Cohen buckiii2 07/14/16 07:24:47 PM
#13   Small insider buy: DewDiligence 05/24/16 08:33:30 PM
#12   3/31/16 cash was $75.5M (after $12.5M burn during 1Q16): DewDiligence 05/12/16 04:21:29 PM
#11   Hey Dew. Added position today. mtfuji 04/15/16 11:54:22 AM
#10   Small purchase by independent director two days ago: DewDiligence 03/30/16 06:25:31 PM
#9   ...And another small purchase on 2/5/16: DewDiligence 02/06/16 09:41:38 AM
#8   Ronald Perelman’s company buys another $120K: DewDiligence 02/04/16 06:42:16 PM
#7   VTVT starts phase-2 trial of TTP273 in T2D: DewDiligence 01/21/16 09:59:51 AM
#5   Ronald Perleman’s company adds slightly to VTVT holding: DewDiligence 01/20/16 05:05:51 PM
#4   Very low float, high institutional ownership. Alzheimer's product docoroc2 01/17/16 11:14:55 AM
#3   VTVT has 2016 phase-2b data readouts in both DewDiligence 01/10/16 12:44:24 PM
#2   Good overview article on VTVT (from 12/15/15): DewDiligence 01/10/16 12:42:11 PM
#1   (ll) etcetera 01/06/16 09:17:40 PM
PostSubject